Diverse perspectives on science and medicine
Researchers from Johns Hopkins University have teamed two powerful technologies to correct sickle cell disease. Linzhao Cheng and colleagues have deployed CRISPR/Cas-9 on iPS cells to replace the mutant beta globin gene. ACRONYMS AND
Stem cell debate and hype continue, with each advance distancing the field from embryos while promising replacement parts as stem cells “turn into” everything from hearts to gizzards. Meanwhile, many researchers have been quietly pursuing the immediate
“My brain! It’s my second favorite organ!” cried an aghast Woody Allen as his time-traveling character in 1973’s Sleeper, Miles Monroe, was about to have his head removed at a robot recycling plant. Because my